Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Christopher Ryan Young is active.

Publication


Featured researches published by Christopher Ryan Young.


Archive | 2012

Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide

Patricia Hurter; William Rowe; Christopher Ryan Young; Adriana Costache; Patrick R. Connelly; Mariusz Krawiec; Yuchuan Gong; Yushi Feng; Martin Trudeau


Archive | 2007

Compositions of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide

Christopher Ryan Young; Charles William Rowe


Archive | 2009

Dosage units of 3-(6-(1-(2,2-difluorobenzo[D] [1,3] dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid

Christopher Ryan Young


Archive | 2008

Formulations of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid

Ali Keshavarz-Shokri; Christopher Ryan Young


Archive | 2011

Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyriodin-2-yl)benzoic acid and administration thereof

Marinus Jacobus Verwijs; Rossitza Gueorguieva Alargova; Ritu Rohit Kaushik; Irina Nikolaevna Kadiyala; Christopher Ryan Young


Archive | 2014

Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid and administration thereof

Marinus Jacobus Verwijs; Rossitza Gueorguieva Alargova; Ritu Rohit Kaushik; Irina Nikolaevna Kadiyala; Christopher Ryan Young


Journal of Pharmaceutical and Biomedical Analysis | 2007

Understanding the degradation pathway of a poorly water-soluble drug formulated in PEG-400

Jianmei Kochling; Hai Miao; Christopher Ryan Young; Adam R. Looker; Michael Shannon; Eda Ross Montgomery


Archive | 2007

COMPOSITIONS OF N-Ý2,4-BIS(1,1-DIMETHYLETHYL)-5-HYDROXYPHENYL¨-1,4-DIHYDRO-4-OXOQUINOLINE-3-CARBOXAMIDE

Christopher Ryan Young; Charles William Rowe


Archive | 2007

Zusammensetzungen aus n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxochinolin-3-carboxamid

Christopher Ryan Young; Charles William Rowe


Archive | 2006

Feste formen von n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxochinolin-3-carboxamid

Patricia Hurter; Yuchuan Gong; Christopher Ryan Young; Patrick R. Connelly; William Rowe; Adriana Costache; Mariusz Krawiec; Yushi Feng; Martin Trudeau

Collaboration


Dive into the Christopher Ryan Young's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Yushi Feng

Vertex Pharmaceuticals

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge